Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy

DOI10.1016/j.jtbi.2022.111394zbMath1506.92050OpenAlexW4312116182MaRDI QIDQ2678792

Brock D. Sherlock, Adelle C. F. Coster

Publication date: 24 January 2023

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2022.111394

zbMATH Keywords

optimisationmathematical modellingparameter inferenceoncolytic virustreatment outcome

Mathematics Subject Classification ID

Medical applications (general) (92C50)

Related Items (1)

Agent-based and continuum models for spatial dynamics of infection by oncolytic viruses

Cites Work

• Modeling and analysis of a virus that replicates selectively in tumor cells
• Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
• A family of embedded Runge-Kutta formulae
• Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
• ODE models for oncolytic virus dynamics
• Optimizing the timing and composition of therapeutic phage cocktails: a control-theoretic approach
• Oncolytic virotherapy for tumours following a Gompertz growth law
• Population models with singular equilibrium

This page was built for publication: Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy